Document Detail


TIPS for management of refractory ascites: response and survival are both unpredictable.
MedLine Citation:
PMID:  12757168     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Refractory ascites is a serious complication of advanced cirrhosis with a 1-year transplant-free survival of 20-50%. The aim of our study was to investigate the short- and long-term effects of transjugular intrahepatic portosystemic shunt (TIPS) in the management of refractory ascites. In all 65 patients (39 M, 26 F; Child B 55%, Child C 45%, mean MELD score 14.8 +/- 6.6) with liver disease (alcoholic 40%, cryptogenic 20%, HCV 14%, others 26%) and refractory ascites were included in this study. Forty-eight (74%) patients had no signs of hepatic encephalopathy (HE), 16 (24%) had mild and 1 (2%) had moderate HE before TIPS; 28 (43%) had mild (> 1.2 and < 2.4 mg/dl) and 6 patients (9%) had moderate (> 2.4 mg/dl) renal dysfunction. Mean follow-up was 55.5 +/- 70.2 weeks. Treatment success, defined as complete response, partial response, and no response, and survival was determined at 3 weeks, and 3, 6, 12, 24, and 36 months after TIPS. TIPS was successful in all patients. Mean portal venous pressure gradient improved significantly after TIPS (24 +/- 8 to 10 +/- 4). During follow-up, 40 (58%) patients died and 17 (27%) patients had liver transplantation (OLT); 20 (31%) patients had 38 shunt revisions due to lack of initial response or recurrence of ascites. The response was assessed in patients who were alive, without OLT, at each time point. Complete response was seen in 10%, 23%, 17%, 11%, 22% and 33%; partial response was seen in 46%, 46%, 40%, 44%, 28%, and 8%; and no response was seen in 44%, 31%, 43%, 41 %, 39%, and 50% at 3 weeks, and 3, 6, 12, 24, and 36 months respectively. There were no pre-TIPS variables that could predict the response at 3 weeks, 3 months, or 6 months. Mild HE was seen in 8 (12%) patients and severe HE was seen in 16 (25%) immediately after TIPS. The mortality at 3 weeks, and 3, 6, 12, 24, and 36 months was 26%, 38%, 46%, 51%, 57%, and 58%, respectively. Three-week (P = 0.01) and 3-month (P = 0.04) mortality was higher in Child C patients compared to Child B. However, there were no independent predictors of survival on multivariate analysis at 3 or 6 months. Child-Pugh score 3 weeks after TIPS was a strong predictor of mortality. In conclusion, in patients with refractory ascites, TIPS was associated with a high mortality and morbidity. The response and the mortality were both unpredictable on the basis of pretransplant variables.
Authors:
Paul J Thuluvath; Jasdeep S Bal; Sally Mitchell; Gunnar Lund; Anthony Venbrux
Related Documents :
21234908 - Tolerance and efficacy of azathioprine in pediatric crohn's disease.
23818758 - Early achievement and maintenance of stable asthma control using initially higher-dose ...
7156928 - Pulmonary arteriovenous fistulas.
14638358 - Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of th...
22519638 - Open rotator cuff repairs in patients 70 years and older.
14741838 - How to avoid brow ptosis after forehead treatment with botulinum toxin.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Digestive diseases and sciences     Volume:  48     ISSN:  0163-2116     ISO Abbreviation:  Dig. Dis. Sci.     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-05-21     Completed Date:  2003-08-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902782     Medline TA:  Dig Dis Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  542-50     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ascites / etiology,  mortality,  therapy*
Female
Follow-Up Studies
Hepatic Encephalopathy / epidemiology,  etiology,  therapy
Humans
Hypertension, Portal / etiology,  mortality,  therapy*
Liver Cirrhosis / complications,  mortality,  therapy*
Liver Function Tests
Logistic Models
Male
Middle Aged
Multivariate Analysis
Paracentesis / statistics & numerical data
Portasystemic Shunt, Transjugular Intrahepatic / adverse effects,  methods*,  mortality
Prosthesis Failure
Severity of Illness Index
Survival Analysis
Survival Rate
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult.
Next Document:  Spontaneous closure of intrahepatic portovenous shunt in a noncirrhotic patient with recurrent encep...